You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Medtronic knows how committed you are to helping patients manage their health. We share your commitment with a passion for providing lifelong solutions that can assist you in managing patients' chronic medical conditions. Our products range from diagnostic equipment to therapies that manage long-term conditions where other medical therapies have failed.
In continuing to this website, you acknowledge you are a registered healthcare professional and I have a valid certification in your possession.
By clicking 'Accept' below you agree that you are a registered healthcare professional and you have a valid certification in your possession.
President and Chief Executive Officer, Amtrak
Director since 2002
Mr. Anderson has been President and Chief Executive Officer of Amtrak, an intercity passenger rail service provider and high-speed rail operator, since July 12, 2017. From 2007 until May 2016, Mr. Anderson served as Chief Executive Officer and a Director of Delta Air Lines, Inc., a commercial airline. Upon retiring as Chief Executive Officer of Delta Air Lines, Inc., he became the Executive Chairman of the Board of Directors of Delta Air Lines, Inc. until October 2016. He was Executive Vice President of UnitedHealth Group Incorporated, a diversified health care company, from 2004 until 2006. Mr. Anderson was Chief Executive Officer of Northwest Airlines Corporation from 2001 to 2004.
Chairman and Chief Executive Officer, Eaton Corporation
Director since 2015
Mr. Arnold has been Chairman and Chief Executive Officer of Eaton Corporation, a power management company, since June 1, 2016. From September 2015 to May 2016, Mr. Arnold served as President and Chief Operating Officer of Eaton Corporation. Prior to that, Mr. Arnold served as the Vice Chairman and Chief Operating Officer, Industrial Sector, of Eaton Corporation. From 2000 to 2008 he served as Senior Vice President of Eaton Corporation and Group Executive of the Fluid Power Group of Eaton. Prior to joining Eaton, Mr. Arnold was employed in a series of progressively more responsible positions at General Electric Company from 1983 to 2000. Mr. Arnold was appointed to the Board of Directors of Eaton Corporation in 2015. Mr. Arnold is a former Director of Covidien plc.
Chairman, President and Chief Executive Officer, Textron, Inc.
Director since 2013
Mr. Donnelly is Chairman, President and Chief Executive Officer of Textron, Inc., a producer of aircraft, defense and industrial products. Mr. Donnelly joined Textron in June 2008 as Executive Vice President and Chief Operating Officer and was promoted to President and Chief Operating Officer in January 2009. He was appointed to the Board of Directors in October 2009, and became Chief Executive Officer of Textron in December 2009 and Chairman of the Board in September 2010. Previously, Mr. Donnelly was the President and CEO of General Electric Company’s aviation business unit, GE Aviation, a leading maker of commercial and military jet engines and components as well as integrated digital, electric power and mechanical systems for aircraft. Prior to July 2005, Mr. Donnelly held various other management positions since joining General Electric in 1989.
Professor of Engineering, Stanford University and co-founder of Plume WiFi and Quantenna Communications, Inc.
Director since 2019
Dr. Goldsmith has served as the Stephen Harris professor in the School of Engineering at Stanford University since 2012 and is director of Stanford’s Wireless Systems Laboratory. She has served as a professor, associate professor or assistant professor at Stanford University since January 1999. Dr. Goldsmith co-founded and served as Chief Technology Officer of Plume WiFi (formerly, Accerlera, Inc.) from August 2010 to August 2014 and Quantenna Communications, Inc. (formerly, mySource Communications, Inc.) from 2005 to 2009 and previously held positions at Maxim Technologies, MemoryLink Corporation and AT&T Bell Laboratories.
Previously, she was an assistant professor of Electrical Engineering at the California Institute of Technology. Dr. Goldsmith currently serves on the Board of Directors for Crown Castle International Corp. She is also co-principal investigator for the NSF Center for Science of Information and is on the technical advisory boards of Sequans Communications and Cohere Technologies. She is a member of the National Academy of Engineering and the American Academy of Arts and Sciences and a Fellow of the Institute of Electrical and Electronics Engineers. Dr. Goldsmith is a frequent lecturer and writer regarding wireless technologies.
Chairman, nVent Electric plc
Director since 2015
Mr. Hogan is Chairman of nVent Electric plc, a manufacturing company for electrical connection and protection products since May 2018. He was previously the Chief Executive Officer of Pentair plc, an industrial manufacturing company, from 2001 until 2018 and served as Chairman from 2002 until 2018. From December 1999 to December 2000, he was President and Chief Operating Officer of Pentair, from March 1998 to December 1999 he was Executive Vice President and President of Pentair’s Electrical and Electronic Enclosures Group. Prior to joining Pentair, he was President of the Carrier Transicold Division of United Technologies Corporation. Before that, he was with the Pratt & Whitney division of United Technologies, General Electric Company and McKinsey & Company. Mr. Hogan served as Chairman of the board of the Federal Reserve Bank of Minneapolis from December 2013 until January 2016. Mr. Hogan is a former director of Covidien plc and Pentair plc.
Executive Chairman and Chairman of the Board, Medtronic plc
Chairman of the Board, Intel
Director since 2011
Mr. Ishrak has been Executive Chairman of Medtronic plc since April 2020, and Chairman of the Board of Medtronic plc since June 2011. Mr. Ishrak served as Chief Executive Officer of Medtronic plc from June 2011 to April 2020. Mr. Ishrak has served as a member of the Board of Directors for Intel, a global technology company, since March 2017. He was named Chairman of the Board for Intel in January 2020. Prior to joining Medtronic, Mr. Ishrak served as President and Chief Executive Officer of GE Healthcare Systems, a comprehensive provider of medical imaging and diagnostic technology, from 2009 to 2011. Before that, Mr. Ishrak was President and Chief Executive Officer of GE Healthcare Clinical Systems from 2005 to 2008 and President and Chief Executive Officer of GE Healthcare Ultrasound and BMD from 1995 to 2004.
Mr. Ishrak was inducted to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows in 2016, and was elected to the National Academy of Engineering in 2020.
Founder and Chairman of Leavitt Partners
Director since 2011
Governor Leavitt has been founder and Chairman of Leavitt Partners, a family of healthcare companies focused on value-based healthcare policy, since 2009. Prior to that he was the United States Secretary of Health and Human Services from 2005 to 2009; Administrator of the Environmental Protection Agency from 2003 to 2005; and Governor of Utah from 1993 to 2003. Governor Leavitt is a former director of Health Equity, Inc.
Financial Consultant and Retired Vice Chairman and
President of Johnson & Johnson
Director since 2007
Mr. Lenehan served as President of Johnson & Johnson, an international pharmaceutical company, from 2002 until 2004, when he retired after 28 years of service to Johnson & Johnson. During those 28 years, Mr. Lenehan also served as Vice Chairman of Johnson & Johnson from 2000 until 2004; Worldwide Chairman of Johnson & Johnson’s Medical Devices and Diagnostics Group from 1999 until he became Vice Chairman of the Board; and Worldwide Chairman, Consumer Pharmaceuticals & Professional Group. Mr. Lenehan has been a financial consultant since 2004, including serving as Senior Advisor of Cerberus Operations and Advisory Company, LLC, a private investment firm. Mr. Lenehan is a former Director of Talecris Biotherapeutics Holding Corp.
Chief Executive Officer, Medtronic plc
Director since 2019
Mr. Martha has been Chief Executive Officer of Medtronic plc since April 27, 2020, and has been a member of the Board of Medtronic since November 2019. Prior to assuming this role, Mr. Martha served as President of Medtronic. Before being named as the next CEO of Medtronic, Mr. Martha served as Executive Vice President and President of Medtronic’s Restorative Therapies Group, a role he held since June 2015. Previously, Mr. Martha served as Senior Vice President of Strategy and Business Development of the Company beginning in January 2015 and of Medtronic, Inc. beginning in August 2011. Prior to that, he served as Managing Director of Business Development at GE Healthcare from April 2007 to July 2011; General Manager for GE Capital Technology Finance Services from November 2003 to March 2007; Senior Vice President, Business Development for GE Capital Vendor Financial Services from February 2002 to October 2003; General Manager for GE Capital Colonial Pacific Leasing from February 2001 to January 2002; and Vice President, Business Development for Potomac Federal, the GE Capital federal financing investment bank from May 1998 to January 2001.
President of Brigham Health
Professor of Medicine, Harvard Medical School
Director since 2014
Elizabeth Nabel, M.D., has been President of Brigham Health, hospitals and physician organisations operating inpatient and outpatient facilities, clinics, primary care health centres, and diagnostic and treatment technologies, research laboratories, and postgraduate medical and scientific education and training programs, as well as Harvard Medical School’s second largest teaching affiliate. Dr. Nabel has also been a Professor of Medicine at Harvard Medical School since 2010. Prior to that, Dr. Nabel held a variety of roles, including Director, at the National Heart, Lung and Blood Institute at the National Institutes of Health, a federal agency funding research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases, from 1999 to 2009. Dr. Nabel is an elected member of the National Academy of Medicine of the National Academy of Sciences.
Private Venture Capital Investor
Director since 2000
Ms. O’Leary is a private venture capital investor. She is also a member of the Board of Directors of American Airlines Group, Inc. She has served on the boards of US Airways, Inc. until that company’s merger with American Airlines at the end of 2013, ALZA Corporation, America West Airlines Group, Inc., Calpine Corporation, Chiron Corporation, Del Monte Foods Company and numerous private companies. Ms. O’Leary is Chair of the Board of Trustees of the University of Denver and is a Trustee of the Bonfils-Stanton Foundation. Additionally, she is a member of the Smithsonian National Board. She was a member of the Stanford University Board of Trustees from 1996 through 2006, where she chaired the Committee of the Medical Center.
Retired Chairman and Chief Executive Officer, General Mills, Inc.
Director since 2007
Mr. Powell was Chairman of General Mills, Inc., an international producer, marketer and distributor of cereals, snacks and processed foods, from 2008 until December 2017 and was Chief Executive Officer of General Mills, Inc. from 2007 until June 2017. He was President and Chief Operating Officer of General Mills, Inc. from 2006 to 2007, and became a Director of General Mills, Inc. in 2006. He was Executive Vice President and Chief Operating Officer, U.S. Retail from 2005 to 2006; and Executive Vice President of General Mills, Inc. from 2004 to 2005. From 1999 to 2004, Mr. Powell was Chief Executive Officer of Cereal Partners Worldwide, a joint venture of General Mills, Inc. and the Nestle Corporation. Mr. Powell joined General Mills, Inc. in 1979. Mr. Powell is a former director of General Mills, Inc.
This information is designed to provide you with helpful educational information but is for information purposes only, is not medical advice, and should not be used as an alternative to speaking with your doctor. No representation is made that the information provided is current, complete, or accurate. Medtronic does not assume any responsibility for persons relying on the information provided. Be sure to discuss questions specific to your health and treatments with a healthcare professional. For more information please speak to your healthcare professional.